OA06811A - Procédé de préparation de nouveaux dérivés de pyridoxine. - Google Patents
Procédé de préparation de nouveaux dérivés de pyridoxine.Info
- Publication number
- OA06811A OA06811A OA57404A OA57404A OA06811A OA 06811 A OA06811 A OA 06811A OA 57404 A OA57404 A OA 57404A OA 57404 A OA57404 A OA 57404A OA 06811 A OA06811 A OA 06811A
- Authority
- OA
- OAPI
- Prior art keywords
- preparation
- pyridoxine derivatives
- new
- new pyridoxine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8016516 | 1980-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA06811A true OA06811A (fr) | 1982-12-31 |
Family
ID=10513518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA57404A OA06811A (fr) | 1980-05-19 | 1981-05-18 | Procédé de préparation de nouveaux dérivés de pyridoxine. |
Country Status (32)
Country | Link |
---|---|
US (1) | US4374841A (xx) |
EP (1) | EP0040591B1 (xx) |
JP (1) | JPS5711966A (xx) |
AR (1) | AR226356A1 (xx) |
AT (1) | ATE3859T1 (xx) |
AU (1) | AU542463B2 (xx) |
BG (1) | BG35327A3 (xx) |
CA (1) | CA1152080A (xx) |
CS (1) | CS223842B2 (xx) |
DD (1) | DD159071A5 (xx) |
DE (1) | DE3160480D1 (xx) |
DK (1) | DK217481A (xx) |
EG (1) | EG15890A (xx) |
ES (1) | ES8203845A1 (xx) |
FI (1) | FI811525L (xx) |
GR (1) | GR82343B (xx) |
HU (1) | HU183441B (xx) |
IE (1) | IE51179B1 (xx) |
IL (1) | IL62602A (xx) |
IN (1) | IN151915B (xx) |
IS (1) | IS1183B6 (xx) |
MA (1) | MA19147A1 (xx) |
NO (1) | NO811680L (xx) |
NZ (1) | NZ196766A (xx) |
OA (1) | OA06811A (xx) |
PL (1) | PL129213B1 (xx) |
PT (1) | PT72992B (xx) |
RO (1) | RO81943A (xx) |
SU (1) | SU1077566A3 (xx) |
YU (1) | YU126281A (xx) |
ZA (1) | ZA812448B (xx) |
ZW (1) | ZW9681A1 (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663354A (en) * | 1984-04-26 | 1987-05-05 | Klinge Pharma Gmbh | Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia |
DE3519693A1 (de) * | 1985-06-01 | 1987-01-02 | Basf Ag | Pyridin-derivate, ihre herstellung und verwendung |
US6051587A (en) * | 1998-04-16 | 2000-04-18 | Medicure, Inc. | Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
JP2002539127A (ja) | 1999-03-08 | 2002-11-19 | メディキュア インコーポレーテッド | ビタミンb−6障害のためのピリドキサル類縁体 |
US6489345B1 (en) | 1999-07-13 | 2002-12-03 | Medicure, Inc. | Treatment of diabetes and related pathologies |
JP2003507418A (ja) * | 1999-08-24 | 2003-02-25 | メディキュア インターナショナル インコーポレイテッド | 心血管疾患とその関連疾患の治療 |
US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
WO2001064692A1 (en) | 2000-02-29 | 2001-09-07 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
JP2003528146A (ja) | 2000-03-28 | 2003-09-24 | メディキュア インターナショナル インコーポレイテッド | 脳血管疾患の治療 |
JP2004502757A (ja) | 2000-07-07 | 2004-01-29 | メディキュア インターナショナル インコーポレイテッド | ピリドキシンおよびピリドキサール類縁体:心血管系治療薬 |
US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
US6897228B2 (en) * | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
US20040121988A1 (en) * | 2001-03-28 | 2004-06-24 | Medicure International Inc. | Treatment of cerebrovascular disease |
JP4048166B2 (ja) * | 2002-11-18 | 2008-02-13 | 三井製糖株式会社 | 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料 |
US20040186077A1 (en) * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents |
EP1608379A1 (en) * | 2003-03-27 | 2005-12-28 | Medicure Inc. | Compositions for treating angina |
CN101014357A (zh) * | 2004-07-07 | 2007-08-08 | 麦迪库瑞国际公司 | 利用血小板聚集药物的组合疗法 |
US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
US20060094749A1 (en) * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents |
US7459468B2 (en) * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
AU2005304220A1 (en) * | 2004-10-28 | 2006-05-18 | Medicure International Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
US20070149485A1 (en) * | 2005-11-28 | 2007-06-28 | Medicure International, Inc. | Selected dosage for the treatment of cardiovascular and related pathologies |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR207133A1 (es) * | 1973-02-20 | 1976-09-15 | Ciba Geigy Ag | Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano |
US4115575A (en) * | 1973-02-20 | 1978-09-19 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)-pyrazines |
GB1485919A (en) * | 1975-08-12 | 1977-09-14 | Grindstedvaerket As | Pyridine derivatives |
DE2711655A1 (de) * | 1977-03-17 | 1978-09-21 | Basf Ag | Pyridinyl-aminoalkylaether |
US4210653A (en) * | 1978-06-27 | 1980-07-01 | Merck & Co., Inc. | Pyridyloxypropanolamines |
-
1981
- 1981-04-07 IL IL62602A patent/IL62602A/xx unknown
- 1981-04-08 NZ NZ196766A patent/NZ196766A/en unknown
- 1981-04-10 IS IS2631A patent/IS1183B6/is unknown
- 1981-04-13 ZA ZA00812448A patent/ZA812448B/xx unknown
- 1981-04-14 GR GR64686A patent/GR82343B/el unknown
- 1981-04-27 ZW ZW96/81A patent/ZW9681A1/xx unknown
- 1981-04-28 BG BG051875A patent/BG35327A3/xx unknown
- 1981-05-02 IN IN465/CAL/81A patent/IN151915B/en unknown
- 1981-05-07 PT PT72992A patent/PT72992B/pt unknown
- 1981-05-07 AR AR285225A patent/AR226356A1/es active
- 1981-05-11 US US06/262,449 patent/US4374841A/en not_active Expired - Fee Related
- 1981-05-12 EG EG260/81A patent/EG15890A/xx active
- 1981-05-13 AU AU70535/81A patent/AU542463B2/en not_active Ceased
- 1981-05-13 MA MA19356A patent/MA19147A1/fr unknown
- 1981-05-15 DE DE8181870023T patent/DE3160480D1/de not_active Expired
- 1981-05-15 PL PL1981231193A patent/PL129213B1/pl unknown
- 1981-05-15 IE IE1085/81A patent/IE51179B1/en unknown
- 1981-05-15 AT AT81870023T patent/ATE3859T1/de not_active IP Right Cessation
- 1981-05-15 YU YU01262/81A patent/YU126281A/xx unknown
- 1981-05-15 CS CS813634A patent/CS223842B2/cs unknown
- 1981-05-15 JP JP7407681A patent/JPS5711966A/ja active Pending
- 1981-05-15 CA CA000377739A patent/CA1152080A/en not_active Expired
- 1981-05-15 EP EP81870023A patent/EP0040591B1/fr not_active Expired
- 1981-05-18 SU SU813289800A patent/SU1077566A3/ru active
- 1981-05-18 DD DD81230039A patent/DD159071A5/de unknown
- 1981-05-18 RO RO81104319A patent/RO81943A/ro unknown
- 1981-05-18 FI FI811525A patent/FI811525L/fi not_active Application Discontinuation
- 1981-05-18 NO NO811680A patent/NO811680L/no unknown
- 1981-05-18 ES ES502276A patent/ES8203845A1/es not_active Expired
- 1981-05-18 OA OA57404A patent/OA06811A/xx unknown
- 1981-05-18 HU HU811402A patent/HU183441B/hu unknown
- 1981-05-18 DK DK217481A patent/DK217481A/da not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA06811A (fr) | Procédé de préparation de nouveaux dérivés de pyridoxine. | |
OA06914A (fr) | Procédé de préparation d'iminodiacides substitués. | |
OA07766A (fr) | Procédé de préparation de dérivés de cephème. | |
OA05928A (fr) | Nouveaux dérivés de céphalosporine, leur procédé de préparation. | |
DZ418A1 (fr) | Dérivés de céphalosporine, leur procédé de préparation et leur application thérapeutique. | |
OA05444A (fr) | Procédé de préparation de nouveaux dérivés benzhydrylsulfinyle. | |
OA07003A (fr) | Préparation de nouveaux dérivés de la furo-(3,4-c) -pyridine. | |
OA04687A (fr) | Procédé de préparation de nouveaux dérivés de l'indole. | |
OA06563A (fr) | Procédé de préparation de nouveaux dérivés d'indolizine. | |
OA05725A (fr) | Procédé de préparation de dérivés d'acides hydroxy-aminophosphonique hydrocarbonés. | |
OA06951A (fr) | Dérivés de la thiéno-pyridinone, leur procédé de préparation et leur application thérapeutique. | |
OA06486A (fr) | Procédé de préparation de 9 aminoalkylfluorènes. | |
OA05385A (fr) | Procédé de préparation de nouveaux dérivés phénoxy. | |
OA07674A (fr) | Procédé de préparation de dérivés de carbapénem, nouveaux intermédiaires de synthèse et préparation de ces intermédiaires. | |
OA06356A (fr) | Procédé de préparation de 2-chlorosulfinylazétidinones. | |
OA05260A (fr) | Procédé de préparation de dérivés d'histidine. | |
OA05485A (fr) | Procédé de préparation de nouveaux dérivés hétérocycliques. | |
OA06274A (fr) | Procédé de préparation de nouveaux composés de type muramyl-péptide. | |
EP0092948A2 (en) | Penicillin derivatives and process for preparation of the same. | |
OA06258A (fr) | Procédé de préparation de nouveaux dérivés acétyléniques de l'androst-4-ène. | |
OA06355A (fr) | Procédé de préparation de 3-exométhylènecépham-sulfoxydes. | |
DZ687A1 (fr) | Dérivés de la chlori-4-furo-(3,4-c)-pyridine et leur procédé de préparation. | |
OA05778A (fr) | Procédé de préparation de dérivés l-(N-acylcarbamoyl) 2-cyano-aziridines. | |
OA07833A (fr) | Procédé de préparation de nouveaux dérivés de 1-(acétylamino)-2-amino-propanone. | |
OA06879A (fr) | Procédé de préparation de dérivés d'hétéroprostaglandines. |